Hem › Thalassemi › New York
Kliniska studier för Thalassemi i New York
4 studier för Thalassemi söker deltagare vid platser i New York.
Städer i New York
Officiell studietext (engelska)
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Columbia University Medical Center_New York_0, New York
- Columbia University Medical Center_New York_0, New York
RekryterarFas 3
Ålder 2 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT06609226ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Western New York BloodCare, Buffalo
- Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
- och 2 fler
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 17 aug. 2026 · NCT04398628A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre
RekryterarFas 2
Ålder 2 till 50 · Alla kön · Uppdaterad 3 juni 2026 · NCT05736419Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
RekryterarFas 3
Ålder 12 till 35 · Alla kön · Uppdaterad 23 mars 2026 · NCT05477563Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.